Medigen Vaccine Biologics Corporation (TPEX:6547)
45.00
-0.75 (-1.64%)
Nov 17, 2026, 1:30 PM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 14.79 billion as of November 17, 2026. It is the 14,806th most valuable company in the world and the 478th biggest in Taiwan. Its market cap has increased by 20.32% in one year.
Market Cap
14.79B
Enterprise Value
13.26B
Revenue
858.93M
Global Rank
Country Rank
#478 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 14.79B, an increase of 421.82%. That is a compound annual growth rate of 15.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 14.79B | 19.21% |
| Dec 31, 2025 | 12.41B | 4.72% |
| Dec 31, 2024 | 11.85B | -48.55% |
| Dec 29, 2023 | 23.04B | 1.10% |
| Dec 30, 2022 | 22.78B | -64.20% |
| Dec 30, 2021 | 63.65B | 192.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 24.07B |
| Sunmax Biotechnology | 20.94B |
| Steminent Biotherapeutics | 18.61B |
| TaiMed Biologics | 17.57B |
| EirGenix | 16.61B |
| Gongwin Biopharm Holdings | 16.59B |
| CHO Pharma | 16.41B |
| Ever Supreme Bio Technology | 14.91B |